share_log

HC Wainwright & Co. Maintains Buy on Unicycive Therapeutics, Lowers Price Target to $4.5

HC Wainwright & Co. Maintains Buy on Unicycive Therapeutics, Lowers Price Target to $4.5

HC Wainwright & Co.維持買入Unicycive Therapeutics,將目標股價下調至4.5美元
Benzinga ·  2023/08/16 06:39

HC Wainwright & Co. analyst Ed Arce maintains Unicycive Therapeutics (NASDAQ:UNCY) with a Buy and lowers the price target from $7 to $4.5.

HC Wainwright & Co. 分析師埃德·阿爾塞維持Unicycive Therapeutics(納斯達克股票代碼:UNCY)的買入,並將目標股價從7美元下調至4.5美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論